MO Altria Group Inc

Altria Holds 2024 Annual Meeting of Shareholders; Declares Regular Quarterly Dividend of $0.98 Per Share

Altria Group, Inc. (Altria) (NYSE: MO) held our 2024 Annual Meeting of Shareholders (Annual Meeting) today. During the Annual Meeting, Billy Gifford, Altria’s Chief Executive Officer, provided brief remarks and addressed shareholder questions. A copy of the presentation and a replay of the webcast are available on .

Preliminary Voting Results

The preliminary voting results from our shareholders at the Annual Meeting were as follows:

  • elected to a one-year term each of the 10 nominees for our Board of Directors (Board) named in our 2024 Proxy Statement;
  • ratified the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for 2024;
  • approved, on an advisory basis, the compensation of our named executive officers; and
  • did not approve two shareholder proposals.

Final voting results will be reported in a Current Report on Form 8-K filed with the U.S. Securities and Exchange Commission.

Regular Quarterly Dividend

Following the Annual Meeting, our Board declared a regular quarterly dividend of $0.98 per share, payable on July 10, 2024, to shareholders of record as of June 14, 2024. The ex-dividend date is June 14, 2024. Future dividend payments remain subject to the discretion of our Board.

Altria’s Profile

We have a leading portfolio of tobacco products for U.S. tobacco consumers age 21+. Our Vision is to responsibly lead the transition of adult smokers to a smoke-free future (Vision). We are Moving Beyond Smoking™, leading the way in moving adult smokers away from cigarettes by taking action to transition millions to potentially less harmful choices - believing it is a substantial opportunity for adult tobacco consumers, our businesses and society.

Our wholly owned subsidiaries include leading manufacturers of both combustible and smoke-free products. In combustibles, we own Philip Morris USA Inc. (PM USA), the most profitable U.S. cigarette manufacturer, and John Middleton Co. (Middleton), a leading U.S. cigar manufacturer. Our smoke-free portfolio includes ownership of U.S. Smokeless Tobacco Company LLC (USSTC), the leading global moist smokeless tobacco (MST) manufacturer, Helix Innovations LLC (Helix), a leading manufacturer of oral nicotine pouches, and NJOY, LLC (NJOY), currently the only e-vapor manufacturer to receive market authorizations from the U.S. Food and Drug Administration (FDA) for a pod-based e-vapor product.

Additionally, we have a majority-owned joint venture, Horizon Innovations LLC (Horizon), for the U.S. marketing and commercialization of heated tobacco stick products.

Our equity investments include Anheuser-Busch InBev SA/NV (ABI), the world’s largest brewer, and Cronos Group Inc. (Cronos), a leading Canadian cannabinoid company.

The brand portfolios of our operating companies include Marlboro®, Black & Mild®, Copenhagen®, Skoal®, on!® and NJOY®. Trademarks related to Altria referenced in this release are the property of Altria or our subsidiaries or are used with permission.

Learn more about Altria at and follow us on X (formerly known as Twitter), Facebook and LinkedIn.

EN
16/05/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Altria Group Inc

 PRESS RELEASE

NJOY Receives First FDA Authorizations for Menthol E-Vapor Products

RICHMOND, Va.--(BUSINESS WIRE)-- Altria Group, Inc. (Altria) (NYSE: MO) announces today that the U.S. Food and Drug Administration (FDA) issued marketing orders for NJOY ACE Pod Menthol 2.4%, NJOY ACE Pod Menthol 5%, NJOY DAILY Menthol 4.5%, and NJOY DAILY Extra Menthol 6%. These authorizations follow FDA review of the Premarket Tobacco Product Applications (PMTA), submitted by NJOY, LLC (NJOY) in March 2020. NJOY ACE remains the only pod-based e-vapor product with marketing authorization from the FDA, and now NJOY has the first and only menthol e-vapor products authorized by the FDA to date...

 PRESS RELEASE

NJOY Submits Premarket Tobacco Product Applications to the FDA for NJO...

RICHMOND, Va.--(BUSINESS WIRE)-- Today, NJOY, an Altria company, announces the submission of a supplemental Premarket Tobacco Product Application (PMTA) to the U.S. Food and Drug Administration (FDA) to commercialize and market the NJOY ACE 2.0 device. This new device incorporates access restriction technology designed to prevent underage use via Bluetooth® connectivity to authenticate the user before unlocking the device. The company also re-submitted PMTAs for Blueberry and Watermelon pod products that work exclusively with the NJOY ACE 2.0 device. “Altria’s Vision is to responsibly lead t...

 PRESS RELEASE

Altria Holds 2024 Annual Meeting of Shareholders; Declares Regular Qua...

RICHMOND, Va.--(BUSINESS WIRE)-- Altria Group, Inc. (Altria) (NYSE: MO) held our 2024 Annual Meeting of Shareholders (Annual Meeting) today. During the Annual Meeting, Billy Gifford, Altria’s Chief Executive Officer, provided brief remarks and addressed shareholder questions. A copy of the presentation and a replay of the webcast are available on . Preliminary Voting Results The preliminary voting results from our shareholders at the Annual Meeting were as follows: elected to a one-year term each of the 10 nominees for our Board of Directors (Board) named in our 2024 Proxy Statem...

Altria Group Inc.: Update to key credit considerations following outlo...

Our credit view of this issuer reflects its low financial leverage and its very strong profitability and operating cash flow, offset by its high dividend payout and share repurchases.

Altria Group Inc: 1 director

A director at Altria Group Inc sold 22,487 shares at 43.953USD and the significance rating of the trade was 70/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearl...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch